WO2011080160A1 - Improvements to nucleic acid elution - Google Patents

Improvements to nucleic acid elution Download PDF

Info

Publication number
WO2011080160A1
WO2011080160A1 PCT/EP2010/070389 EP2010070389W WO2011080160A1 WO 2011080160 A1 WO2011080160 A1 WO 2011080160A1 EP 2010070389 W EP2010070389 W EP 2010070389W WO 2011080160 A1 WO2011080160 A1 WO 2011080160A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
solid matrix
matrix
inulin
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2010/070389
Other languages
English (en)
French (fr)
Inventor
Andrew Francis Page
Breck Olland Parker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare UK Ltd
Global Life Sciences Solutions USA LLC
Original Assignee
GE Healthcare UK Ltd
Whatman Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare UK Ltd, Whatman Inc filed Critical GE Healthcare UK Ltd
Priority to AU2010338349A priority Critical patent/AU2010338349B2/en
Priority to JP2012546416A priority patent/JP5899118B2/ja
Priority to US13/519,391 priority patent/US20120289690A1/en
Priority to CA2785913A priority patent/CA2785913C/en
Priority to EP10796044.5A priority patent/EP2519631B1/en
Priority to CN201080059859.XA priority patent/CN102725406B/zh
Publication of WO2011080160A1 publication Critical patent/WO2011080160A1/en
Anticipated expiration legal-status Critical
Priority to US17/122,606 priority patent/US11725201B2/en
Priority to US18/340,609 priority patent/US12247199B2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Definitions

  • This invention relates to the storage on a solid matrix of genetic material, in particular DNA that has been purified prior to the application to the solid matrix.
  • nucleic acids particularly DNA
  • storage of nucleic acids is typically accomplished in solution using refrigeration either at 4°C for up to several days or -20°C or even lower temperatures for longer periods. This is costly and space consuming for static storage. It presents greater issues when nucleic acid samples require transportation and samples are often shipped in dry ice.
  • Burgoyne (WO 90/03959 ) described a method whereby biological samples, usually blood, could be applied to a solid matrix which combined reagents which lysed the cells. The released DNA was retained on the solid matrix. These samples could be stored for long periods at room temperature.
  • Figure 1 shows the struture of inulin.
  • PEG is prepared in a variety of molecuar weights defined by the average number of subunits per molecule. Polymers of MW 400, 1000 and 3350 were evaluated. It was observed that PEG 1000 produced the best recovery of applied DNA results (data not shown) and was used in the remainder of the tests but is referred to as PEG. At concentration of PEG at about 25% the results varied between experiments; this may imply small inconsistencies in the coating process of the solid matrix at these concentrations.
  • Inulin is a naturally occuring polysaccharide found in many plants. Its structure is given in Figure 1. it is anticpated that simple modifications of inulin eg esterification would be possible and still achieve the improved elution of the applied purified DNA.
  • the purified DNA can be applied to the solid matrix that has been treated with inulin in buffers that are routinely used in nucleic acid chemistry. Up to 10% PEG can also be included in the application buffer.
  • the DNA prior to application to the solid matrix can be purified by a variety of standard laboratory techniques.
  • the solid matrix was FTA Elute 903 matrix from Whatman.
  • a 4 M stock of guanidine thiocyanate was prepared and diluted to 2 M using various concentrations of test reagents.
  • 903 matrix (2 1 ⁇ 4" x 2 1 ⁇ 4") was placed into trays containing guanidine thiocyanate/ test reagent mixes and agitated gently for 10 seconds.
  • Matrices were stored at room temperature in a desiccator until use.
  • Microfuge tubes were placed in a heat block for 30 min at 98°C. 4) Microfuge tubes were pulse vortexed for 60 sec and then briefly centrifuged.
  • Quantification of DNA in eluates was performed by QPCR using a 7900HT Thermal Cycler (Applied Biosystems). Reactions were set up using an RNase P assay and TAQMAN ® Universal PCR Master Mix (Applied Biosystems). A four point standard curve was prepared using a serial dilution from 10 to 0.01 ng/ ⁇ of the same Roche DNA used for experiments. Early QPCR quantifications were performed in 96-well plates and were set up manually. Following the introduction and validation of a liquid handling robot, later quantifications were performed using 384-well plates. Both 96 and 384-well plates were validated and also tested against each other to check for consistency between methods.
  • the matrix containing 20 % inulin showed the highest % recovery of applied purified DNA. Since PEG was also identified as a possible additive to matrix
  • Results were also obtained from experiments where the discs with applied purified DNA had been stored in a dessicator at room temperature. The results showed that the discs could be stored for at least twenty-three days before DNA elution with similar increased recovery of DNA when the matrix had been treated with inulin.
  • Results also showed that the amount of DNA applied and recovered from the test matrix could be as low as lng and as high as ⁇ g (the maximum tested) and the increased effect on inulin treatment was still observed.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PCT/EP2010/070389 2009-12-29 2010-12-21 Improvements to nucleic acid elution Ceased WO2011080160A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AU2010338349A AU2010338349B2 (en) 2009-12-29 2010-12-21 Improvements to nucleic acid elution
JP2012546416A JP5899118B2 (ja) 2009-12-29 2010-12-21 核酸溶出の改良
US13/519,391 US20120289690A1 (en) 2009-12-29 2010-12-21 Nucleic acid elution
CA2785913A CA2785913C (en) 2009-12-29 2010-12-21 Improvements to nucleic acid elution
EP10796044.5A EP2519631B1 (en) 2009-12-29 2010-12-21 Improvements to nucleic acid elution
CN201080059859.XA CN102725406B (zh) 2009-12-29 2010-12-21 核酸洗脱的改进
US17/122,606 US11725201B2 (en) 2009-12-29 2020-12-15 Nucleic acid elution
US18/340,609 US12247199B2 (en) 2009-12-29 2023-06-23 Nucleic acid elution

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29065209P 2009-12-29 2009-12-29
US61/290,652 2009-12-29

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/519,391 A-371-Of-International US20120289690A1 (en) 2009-12-29 2010-12-21 Nucleic acid elution
US17/122,606 Division US11725201B2 (en) 2009-12-29 2020-12-15 Nucleic acid elution

Publications (1)

Publication Number Publication Date
WO2011080160A1 true WO2011080160A1 (en) 2011-07-07

Family

ID=43743431

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/070389 Ceased WO2011080160A1 (en) 2009-12-29 2010-12-21 Improvements to nucleic acid elution

Country Status (7)

Country Link
US (3) US20120289690A1 (enExample)
EP (1) EP2519631B1 (enExample)
JP (1) JP5899118B2 (enExample)
CN (1) CN102725406B (enExample)
AU (1) AU2010338349B2 (enExample)
CA (1) CA2785913C (enExample)
WO (1) WO2011080160A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9534214B2 (en) 2013-10-31 2017-01-03 General Electric Company Substrates and associated methods for elution of nucleic acids
US9719082B2 (en) 2013-10-31 2017-08-01 General Electric Company Substrates and associated methods for elution of nucleic acids

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5899118B2 (ja) * 2009-12-29 2016-04-06 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション 核酸溶出の改良
US9480966B2 (en) 2012-04-30 2016-11-01 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
CN108473932B (zh) 2015-09-09 2022-07-15 集联健康有限公司 用于样品收集、稳定化和保存的系统、方法和装置
US10000742B2 (en) * 2015-11-19 2018-06-19 General Electric Company Device and method of collection for RNA viruses
CN105462961B (zh) * 2016-01-14 2019-04-19 苏州市公安局 一种提取核酸的方法及试剂盒
CA3049458A1 (en) 2017-01-10 2018-07-19 Drawbridge Health, Inc. Devices, systems, and methods for sample collection
JP2021145642A (ja) 2020-03-23 2021-09-27 株式会社リコー 担体及び検査方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003959A1 (en) 1988-10-05 1990-04-19 The Flinders University Of South Australia Solid medium and method for dna storage
US5939259A (en) 1997-04-09 1999-08-17 Schleicher & Schuell, Inc. Methods and devices for collecting and storing clinical samples for genetic analysis
WO2003016552A2 (en) 2001-08-20 2003-02-27 Whatman, Inc. Dna purification and recovery from high particulate and solids samples
WO2003044211A2 (en) * 2001-11-15 2003-05-30 Whatman Inc. Materials and methods for releasing genetic material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496562A (en) * 1988-10-05 1996-03-05 Flinders Technologies Pty Ltd Solid medium and method for DNA storage
GB8903593D0 (en) * 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
US5124444A (en) * 1989-07-24 1992-06-23 Microprobe Corporation Lactam-containing compositions and methods useful for the extraction of nucleic acids
WO2000066606A1 (en) * 1999-04-30 2000-11-09 Whatman, Inc. Substrate including anionic detergent for purifying nucleic acid
SE9904475D0 (sv) * 1999-12-08 1999-12-08 Artursson Nucleic acid delivery system
JP3776334B2 (ja) * 2001-07-11 2006-05-17 株式会社富士薬品 イヌリン含有製剤
EP1442045B1 (en) * 2001-11-06 2009-01-07 Cortex Biochem Inc. Isolation and purification of nucleic acids
US20040033546A1 (en) * 2002-04-10 2004-02-19 The Trustees Of Columbia University In The City Of New York Novel microarrays and methods of use thereof
JP2007519613A (ja) * 2003-10-23 2007-07-19 アルザ・コーポレーシヨン 微小突出部をコーティングするための安定化されたdnaの組成物
US20060153920A1 (en) * 2004-09-24 2006-07-13 Ketan Amin Lyophilized pharmaceutical compositions
US7727718B2 (en) * 2005-01-04 2010-06-01 Molecular Research Center, Inc. Reagents for storage and preparation of samples for DNA analysis
JP5899118B2 (ja) * 2009-12-29 2016-04-06 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション 核酸溶出の改良

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003959A1 (en) 1988-10-05 1990-04-19 The Flinders University Of South Australia Solid medium and method for dna storage
US5939259A (en) 1997-04-09 1999-08-17 Schleicher & Schuell, Inc. Methods and devices for collecting and storing clinical samples for genetic analysis
WO2003016552A2 (en) 2001-08-20 2003-02-27 Whatman, Inc. Dna purification and recovery from high particulate and solids samples
WO2003044211A2 (en) * 2001-11-15 2003-05-30 Whatman Inc. Materials and methods for releasing genetic material

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DE JONGE JORGEN ET AL: "Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 32, no. 1, September 2007 (2007-09-01), pages 33 - 44, XP002629865, ISSN: 0928-0987 *
HINRICHS W L J ET AL: "Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexes", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 103, no. 2, 21 March 2005 (2005-03-21), pages 465 - 479, XP004823759, ISSN: 0168-3659, DOI: DOI:10.1016/J.JCONREL.2004.12.011 *
HINRICHS W L J ET AL: "The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 311, no. 1-2, 27 March 2006 (2006-03-27), pages 237 - 244, XP025113313, ISSN: 0378-5173, [retrieved on 20060327], DOI: DOI:10.1016/J.IJPHARM.2005.12.032 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9534214B2 (en) 2013-10-31 2017-01-03 General Electric Company Substrates and associated methods for elution of nucleic acids
US9719082B2 (en) 2013-10-31 2017-08-01 General Electric Company Substrates and associated methods for elution of nucleic acids

Also Published As

Publication number Publication date
CA2785913C (en) 2019-05-21
CN102725406B (zh) 2016-06-01
US12247199B2 (en) 2025-03-11
CA2785913A1 (en) 2011-07-07
US20230332133A1 (en) 2023-10-19
AU2010338349A1 (en) 2012-06-21
JP5899118B2 (ja) 2016-04-06
CN102725406A (zh) 2012-10-10
EP2519631B1 (en) 2017-02-15
US20210102190A1 (en) 2021-04-08
AU2010338349B2 (en) 2015-03-05
EP2519631A1 (en) 2012-11-07
US11725201B2 (en) 2023-08-15
JP2013515494A (ja) 2013-05-09
US20120289690A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
US12247199B2 (en) Nucleic acid elution
EP3164510B1 (en) Method for separating nucleic acids
WO2002090539A2 (en) Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
US10487322B2 (en) Alkylene glycols and polymers and copolymers thereof for direct isolation of nucleic acid from embedded samples
CA2761059C (en) A dried and stabilized ready-to-use composition containing nucleic acid polymerization enzymes for molecular biology applications
EP2971109A2 (en) Methods for one step nucleic acid amplification of non-eluted samples
Ozkan et al. Comparative evaluation of RNAlater solution and snap frozen methods for gene expression studies in different tissues
EP4186980A1 (en) Automatable method for nucleic acid isolation
WO2017198715A1 (en) Nucleic acid stabilization agent
JP2023138629A (ja) 核の保存方法
EP3164511B1 (en) Methods for amplifying nucleic acids on substrates
CN107002147A (zh) 用于俘获核酸的方法
JP2024067250A (ja) 核酸精製用組成物及び核酸精製方法
WO2025099161A2 (en) Dry storage
KR20250020999A (ko) 혈액 시료 내 성분 고정을 위한 조성물
HK40085645A (en) Automatable method for nucleic acid isolation

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080059859.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10796044

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2010338349

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 5447/DELNP/2012

Country of ref document: IN

ENP Entry into the national phase

Ref document number: 2010338349

Country of ref document: AU

Date of ref document: 20101221

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2010796044

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2012546416

Country of ref document: JP

Ref document number: 13519391

Country of ref document: US

Ref document number: 2010796044

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2785913

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE